Microcrystalline cellulose
- Generic Name
- Microcrystalline cellulose
- Drug Type
- Small Molecule
- CAS Number
- 9004-34-6
- Unique Ingredient Identifier
- BX81F82EWG
- Background
A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.
- Indication
用于体表创伤、外科创面止血及上消化道出血。
- Associated Conditions
- Vaginal burning sensation, Vaginal itching
Retentive Strength of Denture Adhesives on Various RR Ridges
- Conditions
- Retentive Strength of Denture Adhesives
- Interventions
- First Posted Date
- 2021-10-01
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Altamash Institute of Dental Medicine
- Target Recruit Count
- 24
- Registration Number
- NCT05063422
- Locations
- 🇵🇰
Altamash Institute of dental medicine, Karachi, Sindh, Pakistan
A Phase I Study of GT300 in Healthy Subjects
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Generian Pharmaceuticals, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT04963855
To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI
- Conditions
- Upper Respiratory Tract Infection
- Interventions
- Drug: A. PaniculataDrug: A. ChilensisDrug: A. Paniculata and A. Chilensis
- First Posted Date
- 2021-07-08
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Vedic Lifesciences Pvt. Ltd.
- Target Recruit Count
- 225
- Registration Number
- NCT04955327
- Locations
- 🇮🇳
Shree Hospital & Critical Care Center, Nagpur, Maharashtra, India
🇮🇳Apollo Spectra Hospitals, Kanpur, Uttar Pradesh, India
🇮🇳Gillurkar Multispecialty Hospital, Nagpur, Maharashtra, India
Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease
- Conditions
- Sickle Cell Disease
- Interventions
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2021-01-26
- Lead Sponsor
- Yale University
- Target Recruit Count
- 6
- Registration Number
- NCT03978156
- Locations
- 🇺🇸
Yale New Haven Hospital Smilow Cancer Center, New Haven, Connecticut, United States
Safety, Tolerability, Pharmacokinetics and Effects on Transcranial Magnetic Stimulation of Oral Doses of XEN1101
- Conditions
- Healthy Male Volunteers
- Interventions
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2018-09-18
- Lead Sponsor
- Xenon Pharmaceuticals Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03468725
- Locations
- 🇬🇧
King's College Hospital, Brixton, London, United Kingdom
Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2017-11-13
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- Xenon Pharmaceuticals Inc.
- Target Recruit Count
- 130
- Registration Number
- NCT03340220
- Locations
- 🇬🇧
Richmond Pharmacology Ltd., London, United Kingdom
Oral Versus Intravenous Sedation for Ocular Procedures
- Conditions
- SurgerySedation
- Interventions
- First Posted Date
- 2017-08-11
- Last Posted Date
- 2020-08-19
- Lead Sponsor
- Boston Medical Center
- Target Recruit Count
- 327
- Registration Number
- NCT03246724
- Locations
- 🇺🇸
Boston Medical Center, Boston, Massachusetts, United States
Curcumin and Function in Older Adults
- Conditions
- Older AdultsCognitive FunctionPhysical Function
- Interventions
- First Posted Date
- 2017-03-21
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 17
- Registration Number
- NCT03085680
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression Treatment
- Conditions
- DepressionAnxiety Disorder
- Interventions
- First Posted Date
- 2015-06-11
- Last Posted Date
- 2018-09-07
- Lead Sponsor
- Medical University of Bialystok
- Target Recruit Count
- 60
- Registration Number
- NCT02469545
- Locations
- 🇵🇱
Department of Psychiatry, Medical University of Bialystok, Bialystok, Poland
Ramelteon in the Prevention of Post-operative Delirium
- Conditions
- Cognitive DisordersDelayed Emergence From AnesthesiaDeliriumDelirium, Dementia, Amnestic, Cognitive Disorders
- Interventions
- First Posted Date
- 2014-12-24
- Last Posted Date
- 2020-06-30
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 80
- Registration Number
- NCT02324153
- Locations
- 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.